Even as they have revolutionized the treatment of certain forms of cancer, CAR T-cell therapies have been shadowed by a significant limitation: many patients, including those whose cancer goes into full remission, eventually relapse. In a new study, Dana-Farber Cancer Institute researchers report on a technique with the potential to eliminate that problem.
Rising medication costs pose barrier to diabetes treatment, study finds
Actively managing diabetes is crucial to preventing long-term health complications, but rising costs are creating barriers to treatment.
February 19, 2024